Liquid biopsy reveals collateral tissue damage in cancer

by Avniel-Polak, S., Brais, L., Cohen, D., Cohen, J.E, Dor, Y., Glaser, B., Gotkine, M., Grinshpun, A., Grozinsky-Glasberg, S., Hubert, A., Kaplan, T., Kustanovich, A., Lehmann-Werman, R., Loftus, M.F, Loyfer, N., Lubotzky, A., Magenheim, J., Makranz, C., Maoz, M., Moss, J., Mostoslavsky, R., Neiman, D., Ng, K., Ochana, B.-L, Peretz, T., Piyanzin, S., Rokach, A., Salah, A., Shemer, R., Spalding, K.L, Temper, M., Wolpin, B.M, Zemmour, H., Zick, A.
Published 2022

Real-world evidence for option value in metastatic melanoma

by Garrison, L.P., Jr, Lee, W., Li, M., To, T.M, Veenstra, D.L, Wong, W.B
Published 2021

Dissemination patterns and chronology of distant metastasis affect survival of patients with head and neck squamous cell carcinoma

by Baatenburg de Jong, R.J, Berzenji, D., Dronkers, E.A.C, Hardillo, J.A, Keereweer, S., Koljenovic, S., Mast, H., Monserez, D.A, Mureau, M.A.M, Sewnaik, A., van der Lugt, A., van Meerten, E., Verduijn, G.M
Published 2021

Effects of early vs delayed progression on clinical and economic outcomes in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first-line the...

by Bhanegaonkar, A., Dieyi, C., Hutson, T.E, Kasturi, V., Kim, R., Krulewicz, S., Liu, F.X
Published 2021

A phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prosta...

by Agarwal, N., Azad, A., Benzaghou, F., Carles, J., Chowdhury, S., Kerloeguen, Y., Kimura, A., Mcgregor, B., Merseburger, A.S, Mohamed, N., Oudard, S., Pal, S., Panneerselvam, A., Saad, F., Soares, A., Wang, F.
Published 2022

Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk Individuals

by Ausems, M.G.E.M, Bartsch, D.K, Brand, R.E, Bruno, M.J, Cahen, D.L, Canto, M.I, Carrato, A., Chak, A., Chuidian, M., Dbouk, M., Earl, J., Fockens, P., Goggins, M.G, Gress, T.M, Half, E., International Cancer of the Pancreas Screening Consortium, Kastrinos, F., Konings, I.C.A.W, Koopmann, B.D.M, Kwon, R.S, Lachter, J., Levink, I.J.M, Lucas, A.L, Overbeek, K.A, Paiella, S., Poley, J.-W, Stoffel, E.M, Stoita, A., Syngal, S., Thosani, N.C, van Hooft, J.E, Vleggaar, F.P
Published 2022

Incidence of sepsis and associated mortality within the first year after cancer diagnosis in middle aged adults: A US population based study

by Cohrs, A., Leslie, D., Van De Louw, A.
Published 2021

Combined fibrinogen-to-pre-albumin ratio and carbohydrate antigen 19–9 score is a promising metric to predict progression of metastatic colorectal mucinous adenocarcinoma

by Cheng, X.-X, Fu, M., Liao, Y.-C, Wang, X.-F
Published 2021

Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer

by Cardenas, C.E, El-Naggar, A.K, Eraj, S.A, Ferrarotto, R., Frank, S.J, Fuller, C.D, Garden, A.S, Ginsberg, L.E, Gunn, G.B, Hessel, A.C, Hutcheson, K.A, Johnson, J.M, Kamal, M., Lai, S.Y, Lewin, J.S, Messer, J.A, Mohamed, A.S.R, Morrison, W.H, Ng, S.P, Pham, B., Phan, J., Rock, C.D, Rosenthal, D.I, Weber, R.S, Zafereo, M.E
Published 2018

Efficacy and safety of apatinib in recurrent/metastatic nasopharyngeal carcinoma: A pilot study

by Bai, Y., Chua, K.L.M, Chua, M.L.K, Fan, C., Huang, L., Lim, D.W.T, Long, B., Shu, X., Tan, S.H, Wang, Y., Wee, J.T.S, Wu, Y., Xie, Y., Zhang, X.
Published 2021

Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers

by Ambrosini, M., Andre, T., Bergamo, F., Chao, J., Chida, K., Cohen, R., Colle, R., Conca, V., Corti, F., Cremolini, C., Curigliano, G., Elez, M.E, Emmett, M., Fakih, M., Fenocchio, E., Fucà, G., Garciá, M.D, Jayachandran, P., Kawazoe, A., Klempner, S.J, Lonardi, S., Mazzoli, G., Overman, M., Pietrantonio, F., Provenzano, L., Randon, G., Salati, M., Salvatore, L., Shah, A.T, Shitara, K., Svrcek, M.
Published 2022

Identification of seven tumor-educated platelets RNAs for cancer diagnosis

by Cheng, B., Dai, K., Ge, X., Yuan, L.
Published 2021

Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor...

by Blumenschein, G., Jr, Colevas, A.D, Docampo, L.C.I, Even, C., Fayette, J., Ferris, R.L, Gillison, M.L, Guigay, J., Haddad, R., Harrington, K.J, Jayaprakash, V., Kasper, S., Kiyota, N., Li, L., Licitra, L., Lynch, M., Rordorf, T., Saba, N.F, Tahara, M., Vokes, E.E, Worden, F.
Published 2018